Inclinical Partners With Terrosa To Offer Collaborative CTMS Subscription Services
Thousand Oaks, CA-August 5, 2009 Integrated Clinical Solutions (Inclinical) a developer of collaborative clinical operations software for the pharmaceutical, biotechnology and medical device industries, has partnered with Terrosa Technologies (Terrosa) to be its exclusive worldwide sales and distribution agent.
Inclinical and Terrosa have teamed up to bring inclinicalperform, to the clinical trial industry using Software as a Service (SaaS) technology. Terrosa will have exclusive responsibility for the sales of inclinicalperform software as well as developing the go-to-market strategies and sales operations.
Inclinical's, inclinicalperform, provides a collaborative working environment for clinical operations teams comprised of Sponsors, CROs, Sites and other stakeholders. Inclinicalperform provides all the basic functionality of traditional Clinical Trial Management Systems (CTMS) and integrates those functions with collaborative document control and distribution, issue/query resolution and contact resource management. Inclinicalperform is designed to support Title 21 CFR, Part 11, FDA compliance and good Information security practices.
"We are pleased to partner with Integrated Clinical Solutions so that they may maintain their focus on further development of new process automations within inclinicalperform," said Kim Terry, President of Terrosa Technologies. Armerding also stated, "Terrosa's integrated services will allow us to stay focused on what we do best-automating the clinical operations process."
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
